Details for New Drug Application (NDA): 202595
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 202595
Tradename: | OSELTAMIVIR PHOSPHATE |
Applicant: | Natco |
Ingredient: | oseltamivir phosphate |
Patents: | 0 |
Pharmacology for NDA: 202595
Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 202595
Suppliers and Packaging for NDA: 202595
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 202595 | ANDA | Alvogen Inc. | 47781-468 | 47781-468-13 | 1 BLISTER PACK in 1 CARTON (47781-468-13) / 10 CAPSULE in 1 BLISTER PACK |
OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 202595 | ANDA | Alvogen Inc. | 47781-469 | 47781-469-13 | 1 BLISTER PACK in 1 CARTON (47781-469-13) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Aug 3, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
Approval Date: | Aug 3, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
Approval Date: | Aug 3, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription